novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

“Switch” dos AVKs para os NOACs. Como fazer?

30 Agosto 2014

Tiago Gregório
Internista
Unidade de AVC

Lesão renal no doente hipertenso

14 Julho 2014
0

ESC Guidelines 2014 - Non-cardiac Surgery

9 Setembro 2014
0

-->